PAVEL SUMAZIN to Carcinoma, Hepatocellular
This is a "connection" page, showing publications PAVEL SUMAZIN has written about Carcinoma, Hepatocellular.
Connection Strength
1.277
-
Asynchronous transitions from high-risk hepatoblastoma to carcinoma. J Hepatol. 2026 Jul; 85(1):106-116.
Score: 0.498
-
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022 10; 77(4):1026-1037.
Score: 0.383
-
Biallelic ARID1A Alterations : A Promising Novel Biomarker for Risk Stratification and Management in Pediatric Malignant Hepatocellular Tumors. Am J Surg Pathol. 2026 09 01; 50(9):1106-1119.
Score: 0.127
-
Molecular Profiling of a Hepatocellular Neoplasm Not Otherwise Specified (HCN-NOS) Demonstrates Distinct Molecular Features in Hepatoblastoma and HCC-Like Components. Pediatr Dev Pathol. 2024 Mar-Apr; 27(2):169-175.
Score: 0.106
-
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma. Am J Pathol. 2019 05; 189(5):1077-1090.
Score: 0.077
-
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma. Sci Rep. 2017 12 19; 7(1):17751.
Score: 0.071
-
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
Score: 0.016